News
Women who survive cancer are more likely to experience cancer-related fatigue and depression than men, according to new ...
According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...
18h
MedPage Today on MSNNew Standard of Care in Locally Advanced Head and Neck CancerAdding pembrolizumab (Keytruda), before and after surgery, to standard adjuvant therapy for locally advanced head and neck ...
22h
MedPage Today on MSNPD-1 Inhibitor Helps Patients With dMMR Tumors Avoid SurgeryNeoadjuvant PD-1 blockade in dMMR tumors "could potentially eradicate the need for chemotherapy, radiation, and surgery in ...
TNX-1700 is in preclinical development for gastric and colorectal cancers ...
With the American Association for Cancer Research’s annual conference now underway, oncology researchers can expect ...
The AACR meeting was full of promising data on the vaccine against cervical cancer, a lung cancer drug and the next ...
Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune ...
Lyon, France-based late-stage clinical biotech MaaT Pharma has presented new preclinical data for MaaT034 at the American ...
Lyon, France-based late-stage clinical biotech MaaT Pharma has presented new preclinical data for MaaT034 at the American ...
The addition of neoadjuvant and adjuvant pembrolizumab to standard of care significantly improved outcomes for certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results